Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT-P17 vs Humira in Rheumatoid Arthritis
NCT03789292Phase 3Completed
- Sponsor
- Celltrion
- Start
- Nov 2018
- Primary completion
- Oct 2019
- Countries
- 1
01
Overview
A Phase 3 trial of RT-105 in rheumatoid arthritis (RA), sponsored by Celltrion. Started Nov 2018; status: completed.
02
Drugs
RT-105
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03789292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03789292.